CiVi Biopharma Inc is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular and metabolic therapies that have meaningful value to patients. The company has multiple assets in various stages of development including Intravenous Iloprost in Phase 3 trials for treatment of Systemic Sclerosis.
Founded in 2016, by Chief Scientific Officer Henrik Oerum and led by CEO Shal ...
CiVi Biopharma Inc is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular and metabolic therapies that have meaningful value to patients. The company has multiple assets in various stages of development including Intravenous Iloprost in Phase 3 trials for treatment of Systemic Sclerosis.
Founded in 2016, by Chief Scientific Officer Henrik Oerum and led by CEO Shal Jacobovitz, the company is headquartered in Washington, DC with research and development offices in the Greater Philadelphia Area.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.